Structural mechanism of Roquin-RNA interactions linked to autoimmunity
Structural mechanism of Roquin-RNA interactions linked to autoimmunity
批准号:
248331224
负责人:
Dr. Andreas Schlundt
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2014
资助国家:
德国
项目状态:
已结题
起止时间:
2013-12-31 至 2016-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Autoimmune diseases still pose a major challenge to modern civilizations. While many disastrous infections, caused by invading pathogens, have been contained during the past century, a growing number of patients suffer from autoimmune diseases and/or hypersensitivity against allergens. Understanding molecular mechanisms of autoimmune reactions is a key approach towards successful and specific treatment. An important role for the immune response is ascribed to T-cell co-stimulatory receptors. This study, exemplarily, aims at revealing the molecular details of the repression of the inducible T cell co-stimulatory surface receptor (ICOS) by the RNA binding protein Roquin. The expression of ICOS is known to be regulated post-transcriptionally by so far unknown mechanisms. ICOS mRNA is surveyed by Roquin and dysregulation is a major cause for systemic autoimmunity with symptoms known from Lupus Erythematosus, mainly displayed through the destruction of connective tissue. Besides ICOS, the proposed study will include additional well-described Roquin mRNA targets like Ox40 and TNF-alpha to also investigate the suppression of respective cell surface receptors on the structural level.Molecular functions and the three-dimensional structure of Roquin are largely unknown. This study therefore aims at investigating structural details of Roquin, its binding to the ICOS- and other mRNAs, and eventually the recruitment of co-factors. Roquin comprises RING and zinc finger domains and a novel domain, termed ROQ, which is required for RNA binding. The proposed research aims at revealing the structural details of RNA binding by the ROQ domain and elucidating molecular mechanisms of the regulation of immune responses at the level of mRNA. The research will focus on experimental structural biology, using nuclear magnetic resonance (NMR) spectroscopy and X-ray crystallography, biochemical and biophysical studies to characterize the molecular interactions combined with functional analysis (in collaboration). Examining Roquin's structure in complex with ICOS- and other mRNAs is expected to reveal a molecular mechanism of autoimmunity that will have more general implications for the regulation of immunity at the level of mRNA.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1038/nsmb.2855
发表时间:
2014-08-01
期刊:
NATURE STRUCTURAL & MOLECULAR BIOLOGY
影响因子:
16.8
作者:
[Schlundt, Andreas, Heinz, Gitta A., Sattler, Michael]
通讯作者:
Sattler, Michael
RNA recognition by Roquin in posttranscriptional gene regulation
Roquin 在转录后基因调控中的 RNA 识别
DOI:
10.1002/wrna.1333
发表时间:
2016
期刊:
Wiley Interdisciplinary Reviews: RNA
影响因子:
--
作者:
[Schlundt A, Niessing D, Heissmeyer V, Sattler M]
通讯作者:
Sattler M
Cis- and trans-acting determinants of mRNA stability, structure and fate (as a continuation)
-
批准号:404540462
-
项目类别:Independent Junior Research Groups
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Dr. Andreas Schlundt
-
依托单位:
国内基金
海外基金
登录
查看更多内容
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
-
批准号:82371634
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵福军
-
依托单位:
PRNP调控巨噬细胞M2极化并减弱吞噬功能促进子宫内膜异位症进展的机制研究
-
批准号:82371651
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵栋
-
依托单位:
CBP/p300-HADH轴在基础胰岛素分泌调节中的作用和机制研究
-
批准号:82370798
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王晓
-
依托单位:
生物钟核受体Rev-erbα在缺血性卒中神经元能量代谢中的改善作用及机制研究
-
批准号:82371332
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:胡琴
-
依托单位:
TIPE2调控巨噬细胞M2极化改善睑板腺功能障碍的作用机制研究
-
批准号:82371028
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵慧
-
依托单位:
慢性炎症诱发骨丢失的机制及外泌体靶向治疗策略研究
-
批准号:82370889
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:傅德皓
-
依托单位:
配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
-
批准号:82371616
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姚晨成
-
依托单位:
超声驱动压电效应激活门控离子通道促眼眶膜内成骨的作用及机制研究
-
批准号:82371103
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:阮静
-
依托单位:
5'-tRF-GlyGCC通过SRSF1调控RNA可变剪切促三阴性乳腺癌作用机制及干预策略
-
批准号:82372743
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈卓佳
-
依托单位:
骨髓ISG+NAMPT+中性粒细胞介导抗磷脂综合征B细胞异常活化的机制研究
-
批准号:82371799
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:杨程德
-
依托单位: